nach oben

Erschienen in:

2018 | OriginalPaper | Buchkapitel

10. Störung der Frühschwangerschaft und Aborte

verfasst von : Stephanie Pildner von Steinburg, Ekkehard Schleußner, Ruben Kuon, Kilian Vomstein, Bettina Toth

Erschienen in: Die Plazenta

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Klinische, laborchemische und sonografische Methoden erlauben die frühe und zuverlässige Diagnose und Beurteilung einer Frühschwangerschaft. Die serielle Bestimmung des humanen Choriongonadotropins (hCG) gestattet eine Unterscheidung zwischen intakter und gestörter Implantation. Mit der transvaginalen Sonografie können Informationen über den Implantationsort, die Vitalität des Embryos und das Vorliegen einer Mehrlingsschwangerschaft gewonnen werden. Zudem ermöglicht die sonografische Beurteilung eine weitgehend zuverlässige Bestimmung des Gestationsalters. Unter dem Begriff „Abort“ wird im deutschsprachigen Raum ein (nichtartifizieller) Verlust der Schwangerschaft vor Eintritt der Lebensfähigkeit des Kindes verstanden. Von Bedeutung ist hierbei die Unterscheidung zwischen sporadischen und habituellen Aborten, wobei ein habituelles Abortgeschehen bei 3 oder mehr aufeinanderfolgenden Fehlgeburten vorliegt. Im ersten Kapitelteil wird auf die klinischen Stadien und die vielfältigen Ursachen von sporadischen Aborten eingegangen, währendem der zweite Kapitelteil die habituellen Aborte und ihre Risikofaktoren behandelt.

Vorheriges Kapitel Plazentabildgebung

Nächstes Kapitel Plazentainsuffizienz/Plazentaassoziierte Erkrankungen

Aleman A, Althabe F, Belizán J, Bergel E (2010) Bed rest during pregnancy for preventing miscarriage. Cochrane Database Syst Rev (2):CD003576

Best D, Avenell A, Bhattacharya S (2017) How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update 13:1–25

Boots C, Stephenson MD (2011) Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med 29:507–513CrossRef

Buchmayer SM, Sparen P, Cnattingius S (2004) Previous pregnancy loss: risks related to severity of preterm delivery. Am J Obstet Gynecol 191(4):1225–1231CrossRef

Carp H (2012) A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol 28:983–990CrossRef

Carp H (2015) A systematic review of dydrogesterone for the treatment of recurrent miscarriage. Gynecol Endocrinol 31:422–430CrossRef

Devaseelan P, Fogarty PP, Regan L (2010) Human chorionic gonadotrophin for threatened miscarriage. Cochrane Database Syst Rev (5):CD007422

Deutsche Diabetes-Gesellschaft (2014) S3-Leitlinie. Diabetes und Schwangerschaft. AWMF Register-Nr. 057/023, Stand 12/2014. http://www.awmf.org/uploads/tx_szleitlinien/057-023l_S3_Diabetes_und_Schwangerschaft_2014-12.pdf. Zugegriffen: 15. Nov. 2017

Finkielman JD, De Feo FD, Heller PG, Afessa B (2004) The clinical course of patients with septic abortion admitted to an intensive care unit. Intensive Care Med 30:1097–1102CrossRef

Friedler S, Margalioth EJ, Kafka I, Yaffe H (1993) Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy – a prospective study. Hum Reprod 8:442–444CrossRef

Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P (2001) Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 7:161–174CrossRef

Jauniaux E, Johns J, Burton GJ (2005) The role of ultrasound imaging in diagnosing and investigating early pregnancy failure. Ultrasound Obstet Gynecol 25:613–624CrossRef

Kalousek DK, Barrett IJ, Gartner AB (1992) Spontaneous abortion and confined chromosomal mosaicism. Hum Genet 88:642–646CrossRef

Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L (2017) Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev 1: CD007223

Merz E, Meinel K, Bald R, Bernaschek G et al. (2004) DEGUM-Stufe-III-Empfehlung zur „weiterführenden” sonographischen Untersuchung (= DEGUM-Stufe II) im Zeitraum 11–14 Schwangerschaftswochen. Ultraschall in Med 25(4): 299–301

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306CrossRef

Morrill MY, Schimpf MO, Abed H, Carberry C, Margulies RU, White AB, Lowenstein L, Ward RM, Balk EM, Uhlig K, Sung VW (2013) Antibiotic prophylaxis for selected gynecologic surgeries. Int J Gynaecol Obstet 120:10–15CrossRef

Poujade O, Grossetti A, Mougel L, Ceccaldi PF, Ducarme G, Luton D (2011) Risk of synechiae following uterine compression sutures in the management of major postpartum haemorrhage. BJOG 118:433–439CrossRef

Prummel MF, Wiersinga WM (2004) Thyroid autoimmunity and miscarriage. Eur J Endocrinol 150:751–755CrossRef

Rai R, Clifford K, Regan L (1996) The modern preventive treatment of recurrent miscarriage. Br J Obstet Gynaecol 103:106–110CrossRef

Reid SM, Middleton P, Cossich MC, Crowther CA (2010) Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev (5):CD007752

Rempen A. Vaginale Sonographie im ersten Trimenon (1991) I. Qualitative Parameter. Z Geburtshilfe Perinatol; 195:114–122

Sneider K, Christiansen OB, Sundtoft IB, Langhoff-Roos J (2016) recurrence of second trimester miscarriage and extreme preterm delivery at 16–27 weeks of gestation with a focus on cervical insufficiency and prophylactic cerclage. Acta Obstet Gynecol Scand 95(12):1383–1390CrossRef

Speroff L, Glass RH, Kase NG (1994) Clin Gynecolo Endocrinol Infertil, 5. Aufl. Williams & Wilkins, Baltimore

Stray-Pedersen B, Stray-Pedersen S (1984) Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 148:140–146CrossRef

Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW (2004) Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol 104(4):784–788CrossRef

Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L (2006) Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial miscarriage treatment (MIST) trial. Br Med J 332:1235–1240CrossRef

van Oostrum N, De Sutter P, Meys J, Verstraelen H (2013) Risks associated with bacterial vaginosis in infertility patients: A systematic review and meta-analysis. Hum Reprod 28:1809–1815CrossRef

Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA (2011) Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev (12): CD005943

Warren JE, Silver RM (2008) Genetic of pregnancy loss. Clin Obstet Gynecol 51:84–95CrossRef

Zolghadri J, Tavana Z, Kazerooni T, Soveid M, Taghieh M (2008) Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study. Fertil Steril 90:727–730CrossRef

Abalovich M, Amino N, Barbour LA et al (2007) Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 92(8 Suppl):1–47CrossRef

Alijotas-Reig J, Ferrer-Oliveras R, Group ES (2012) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report. Lupus 21(7):766–768. https://doi.org/10.1177/0961203312440058CrossRef

Anselmo J, Cao D, Karrison T et al (2004) Fetal loss associated with excess thyroid hormone exposure. JAMA 292(6):691–695. https://doi.org/10.1001/jama.292.6.691CrossRefPubMed

Arachchillage DR, Machin SJ, Mackie IJ, Cohen H (2015) Diagnosis and management of non-criteria obstetric antiphospholipid syndrome. Thromb Haemost 113(1):13–19. https://doi.org/10.1160/TH14-05-0416CrossRefPubMed

Bayer-Garner IB, Korourian S (2001) Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Mod Pathol 14(9):877–879. https://doi.org/10.1038/modpathol.3880405CrossRefPubMed

Bayer-Garner IB, Nickell JA, Korourian S (2004) Routine syndecan-1 immunohistochemistry aids in the diagnosis of chronic endometritis. Arch Pathol Lab Med 128(9):1000–1003. https://doi.org/10.1043/1543-2165(2004)128<1000:RSIAIT>2.0.co;2CrossRefPubMed

Bouet PE, El Hachem H, Monceau E et al (2016) Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril 105(1):106–110. https://doi.org/10.1016/j.fertnstert.2015.09.025CrossRefPubMed

Branch DW, Gibson M, Silver RM (2010) Clinical practice Recurrent miscarriage. N Engl J Med 363(18):1740–1747. https://doi.org/10.1056/NEJMcp1005330CrossRefPubMed

Chen Y-q, Fang R-l, Luo Y-n, Luo C-q (2016) Analysis of the diagnostic value of CD138 for chronic endometritis, the risk factors for the pathogenesis of chronic endometritis and the effect of chronic endometritis on pregnancy: a cohort study. BMC Women’s Health 16(1). https://doi.org/10.1186/s12905-016-0341-3

Cicinelli E, De Ziegler D, Nicoletti R et al (2009) Poor reliability of vaginal and endocervical cultures for evaluating microbiology of endometrial cavity in women with chronic endometritis. Gynecol Obstet Invest 68(2):108–115. https://doi.org/10.1159/000223819CrossRefPubMed

Cicinelli E, Matteo M, Tinelli R et al (2014) Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod 30(2):323–330. https://doi.org/10.1093/humrep/deu292CrossRefPubMed

Cicinelli E, Resta L, Nicoletti R et al (2005) Endometrial micropolyps at fluid hysteroscopy suggest the existence of chronic endometritis. Hum Reprod 20(5):1386–1389. https://doi.org/10.1093/humrep/deh779CrossRefPubMed

Clifford K, Flanagan AM, Regan L (1999) Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 14(11):2727–2730CrossRef

Cohn DM, Goddijn M, Middeldorp S et al (2010) Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost 8(10):2208–2213. https://doi.org/10.1111/j.1538-7836.2010.04015.xCrossRefPubMed

Committee on Practice Bulletins-Obstetrics AC O & Gynecologists (2012) Practice Bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol 120(6): 1514–1521. https://doi.org/10.1097/01.AOG.0000423816.39542.0f

De Braekeleer M, Dao TN (1990) Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod 5(5):519–528CrossRef

Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50(4):1028–1039. https://doi.org/10.1002/art.20105CrossRefPubMed

Di Pietro C, Cicinelli E, Guglielmino MR et al (2013) Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol 69(5):509–517. https://doi.org/10.1111/aji.12076CrossRefPubMed

El Hachem H, Crepaux V, May-Panloup P et al (2017) Recurrent pregnancy loss: current perspectives. Int J Women’s Health 9:331–345. https://doi.org/10.2147/ijwh.s100817CrossRef

Empson M, Lassere M, Craig J, Scott J (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev (2):CD002859. https://doi.org/10.1002/14651858.CD002859.pub2

Empson M, Lassere M, Craig JC, Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99(1):135–144PubMed

Gardiner C, Hills J, Machin SJ, Cohen H (2013) Diagnosis of antiphospholipid syndrome in routine clinical practice. Lupus 22(1):18–25. https://doi.org/10.1177/0961203312460722CrossRefPubMedPubMedCentral

Greenwood SM, Moran JJ (1981) Chronic endometritis: morphologic and clinical observations. Obstet Gynecol 58(2):176–184PubMed

Johnston-MacAnanny EB, Hartnett J, Engmann LL et al (2010) Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril 93(2):437–441. https://doi.org/10.1016/j.fertnstert.2008.12.131CrossRefPubMed

Kamoi M, Fukui A, Kwak-Kim J et al (2015) NK22 cells in the uterine mid-secretory endometrium and peripheral blood of women with recurrent pregnancy loss and unexplained infertility. Am J Reprod Immunol 73(6):557–567. https://doi.org/10.1111/aji.12356CrossRefPubMed

Kannar V, Lingaiah HK, Sunita V (2012) Evaluation of endometrium for chronic endometritis by using syndecan-1 in abnormal uterine bleeding. J Lab Phys 4(2):69. https://doi.org/10.4103/0974-2727.105584CrossRef

Karami N, Boroujerdnia MG, Nikbakht R, Khodadadi A (2012) Enhancement of peripheral blood CD56(dim) cell and NK cell cytotoxicity in women with recurrent spontaneous abortion or in vitro fertilization failure. J Reprod Immunol 95(1–2):87–92. https://doi.org/10.1016/j.jri.2012.06.005CrossRefPubMed

Kasius JC, Fatemi HM, Bourgain C et al (2011) The impact of chronic endometritis on reproductive outcome. Fertil Steril 96(6):1451–1456. https://doi.org/10.1016/j.fertnstert.2011.09.039CrossRefPubMed

King K, Smith S, Chapman M, Sacks G (2010) Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage. Hum Reprod 25(1):52–458. https://doi.org/10.1093/humrep/dep349CrossRefPubMed

Kitaya K (2011) Prevalence of chronic endometritis in recurrent miscarriages. Fertil Steril 95(3):1156–1158. https://doi.org/10.1016/j.fertnstert.2010.09.061CrossRefPubMed

Kitaya K, Tada Y, Hayashi T et al (2014) Comprehensive endometrial immunoglobulin subclass analysis in infertile women suffering from repeated implantation failure with or without chronic endometritis. Am J Reprod Immunol 72(4):386–391. https://doi.org/10.1111/aji.12277CrossRefPubMed

Kitaya K, Tada Y, Taguchi S et al (2012) Local mononuclear cell infiltrates in infertile patients with endometrial macropolyps versus micropolyps. Hum Reprod 27(12):3474–3480. https://doi.org/10.1093/humrep/des323CrossRefPubMed

Koo HS, Kwak-Kim J, Yi HJ et al (2015) Resistance of uterine radial artery blood flow was correlated with peripheral blood NK cell fraction and improved with low molecular weight heparin therapy in women with unexplained recurrent pregnancy loss. Am J Reprod Immunol 73(2):175–184. https://doi.org/10.1111/aji.12316CrossRefPubMed

Koopman LA, Kopcow HD, Rybalov B et al (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198(8):1201–1212. https://doi.org/10.1084/jem.20030305CrossRefPubMedPubMedCentral

Kuon RJ, Togawa R, Vomstein K et al (2017a) Higher prevalence of colonization with Gardnerella vaginalis and gram-negative anaerobes in patients with recurrent miscarriage and elevated peripheral natural killer cells. J Reprod Immunol 120:15–19. https://doi.org/10.1016/j.jri.2017.03.001CrossRefPubMed

Kuon RJ, Vomstein K, Weber M et al (2017b) The “killer cell story” in recurrent miscarriage: Association between activated peripheral lymphocytes and uterine natural killer cells. J Reprod Immunol 119:9–14. https://doi.org/10.1016/j.jri.2016.11.002CrossRefPubMed

Kuon RJ, Weber M, Heger J et al. (2017c) Uterine natural killer cells in patients with idiopathic recurrent miscarriage. Am J Reprod Immunol 78(4). https://doi.org/10.1111/aji.12721CrossRef

Kwak JY, Beaman KD, Gilman-Sachs A et al (1995) Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 34(2):93–99CrossRef

Lachapelle MH, Miron P, Hemmings R, Roy DC (1996) Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. altered profile and pregnancy outcome. J Immunol 156(10):4027–4034PubMed

Lash GE, Schiessl B, Kirkley M et al (2006) Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 80(3):572–580. https://doi.org/10.1189/jlb.0406250CrossRefPubMed

Laurino MY, Bennett RL, Saraiya DS et al (2005) Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. J Genet Couns 14(3):165–181. https://doi.org/10.1007/s10897-005-3241-5CrossRefPubMed

Lyall F, Robson SC, Bulmer JN (2013) Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertens 62(6):1046–1054. https://doi.org/10.1161/HYPERTENSIONAHA.113.01892CrossRef

Mak A, Cheung MW, Cheak AA, Ho RC (2010) Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 49(2):281–288. https://doi.org/10.1093/rheumatology/kep373CrossRef

McQueen DB, Bernardi LA, Stephenson MD (2014) Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril 101(4):1026–1030. https://doi.org/10.1016/j.fertnstert.2013.12.031CrossRefPubMed

McQueen DB, Perfetto CO, Hazard FK, Lathi RB (2015) Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril 104(4):927–931. https://doi.org/10.1016/j.fertnstert.2015.06.044CrossRefPubMed

Michimata T, Ogasawara MS, Tsuda H et al (2002) Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 47(4):196–202CrossRef

Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.xCrossRefPubMed

Ozgur K, Bulut H, Berkkanoglu M, Coetzee K (2017) Reproductive outcomes of IVF patients with unicornuate uteri. Reprod Biomed Online 34(3):312–318. https://doi.org/10.1016/j.rbmo.2016.12.013CrossRefPubMed

Park HJ, Kim YS, Yoon TK, Lee WS (2016) Chronic endometritis and infertility. Clin Exp Reprod Med 43(4):185. https://doi.org/10.5653/cerm.2016.43.4.185CrossRefPubMedPubMedCentral

Plaisier M, Dennert I, Rost E et al (2009) Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions. Hum Reprod 24(1):185–197. https://doi.org/10.1093/humrep/den296CrossRefPubMed

Quenby S, Bates M, Doig T et al (1999) Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 14(9):2386–2391CrossRef

Quenby S, Nik H, Innes B et al (2009) Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod 24(1):45–54. https://doi.org/10.1093/humrep/den348CrossRefPubMed

Raga F, Casan EM, Bonilla-Musoles F (2009) Expression of vascular endothelial growth factor receptors in the endometrium of septate uterus. Fertil Steril 92(3):1085–1090. https://doi.org/10.1016/j.fertnstert.2008.07.1768CrossRefPubMed

Roberts LN, Patel RK, Arya R (2009) Venous thromboembolism and ethnicity. Br J Haematol 146(4):369–383. https://doi.org/10.1111/j.1365-2141.2009.07786.xCrossRefPubMed

Romero R, Espinoza J, Mazor M (2004) Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril 82(4):799–804. https://doi.org/10.1016/j.fertnstert.2004.05.076CrossRefPubMed

Salim R, Regan L, Woelfer B et al (2003) A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 18(1):162–166CrossRef

Seshadri S, Sunkara SK (2014) Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update 20(3):429–438. https://doi.org/10.1093/humupd/dmt056CrossRef

Shimada S, Kato EH, Morikawa M et al (2004) No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 19(4):1018–1024. https://doi.org/10.1093/humrep/deh159CrossRefPubMed

Sugiura-Ogasawara M, Ozaki Y, Katano K et al (2011) Uterine anomaly and recurrent pregnancy loss. Semin Reprod Med 29(6):514–521. https://doi.org/10.1055/s-0031-1293205CrossRefPubMed

Toth B, Vocke F, Rogenhofer N et al (2008) Paternal thrombophilic gene mutations are not associated with recurrent miscarriage. Am J Reprod Immunol 60(4):325–332. https://doi.org/10.1111/j.1600-0897.2008.00630.xCrossRefPubMed

Tuckerman E, Laird SM, Prakash A, Li TC (2007) Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 22(8):2208–2213. https://doi.org/10.1093/humrep/dem141CrossRef

Ziakas PD, Pavlou M, Voulgarelis M (2010) Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 115(6):1256–1262. https://doi.org/10.1097/AOG.0b013e3181deba40CrossRefPubMed

Zolghadri J, Momtahan M, Aminian K et al (2011) The value of hysteroscopy in diagnosis of chronic endometritis in patients with unexplained recurrent spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 155(2):217–220. https://doi.org/10.1016/j.ejogrb.2010.12.010CrossRefPubMed

Titel: Störung der Frühschwangerschaft und Aborte
verfasst von: Stephanie Pildner von Steinburg
Ekkehard Schleußner
Ruben Kuon
Kilian Vomstein
Bettina Toth
Verlag: Springer Berlin Heidelberg
Buch: Die Plazenta
Print ISBN: 978-3-662-55621-4

Electronic ISBN: 978-3-662-55622-1

Copyright-Jahr: 2018
DOI: https://doi.org/10.1007/978-3-662-55622-1_10

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten